{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:03:02Z","timestamp":1782842582654,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2015.11.023","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T00:14:04Z","timestamp":1448151244000},"page":"6417-6425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies"],"prefix":"10.1016","volume":"34","author":[{"given":"Laurent","family":"Coudeville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Baurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeta","family":"Vergu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.11.023_bib0205","series-title":"Dengue and dengue haemorrhagic fever, fact sheet No. 117","author":"World Health O","year":"2015"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0215","first-page":"299","article-title":"Epidemiology of dengue: past, present and future prospects","volume":"5","author":"Murray","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0220","doi-asserted-by":"crossref","first-page":"114ra28","DOI":"10.1126\/scitranslmed.3003084","article-title":"Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity","volume":"3","author":"OhAinle","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0225","first-page":"1","article-title":"Advances in the development of vaccines for dengue fever","volume":"2","author":"Simmons","year":"2012","journal-title":"Vaccine: Dev Ther"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0230","first-page":"1000162","article-title":"Safety and immunogenicity of recombinant, live attenuated tetravalent dengue vaccine (CYD-TDV) in healthy Vietnamese adults and children","volume":"3","author":"Tran","year":"2012","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0235","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4161\/hv.21224","article-title":"Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2\u201345y: Phase II randomized controlled trial in Singapore","volume":"8","author":"Leo","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0240","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2\u201311 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru","volume":"30","author":"Lanata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0245","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0250","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0255","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0260","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0270","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0280","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1371\/journal.pntd.0001450","article-title":"Assessing the potential of a candidate dengue vaccine with mathematical modeling","volume":"6","author":"Group W-VDVM","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0285","doi-asserted-by":"crossref","first-page":"e51244","DOI":"10.1371\/journal.pone.0051244","article-title":"Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination","volume":"7","author":"Coudeville","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0290","unstructured":"Coudeville L, Baurin N, L\u2019azou M, Guy B. Potential impact of dengue vaccination: insights from two large-scale phase III trials with the tetravalent dengue vaccine. Vaccine. Submittted."},{"key":"10.1016\/j.vaccine.2015.11.023_bib0295","doi-asserted-by":"crossref","first-page":"e2126","DOI":"10.1371\/journal.pntd.0002126","article-title":"Challenges in the interpretation of dengue vaccine trial results","volume":"7","author":"Rodriguez-Barraquer","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0300","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a115884","article-title":"Direct and indirect effects in vaccine efficacy and effectiveness","volume":"133","author":"Halloran","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1098\/rsif.2008.0172","article-title":"Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems","volume":"6","author":"Toni","year":"2009","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0310","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.0607208104","article-title":"Sequential Monte Carlo without likelihoods","volume":"104","author":"Sisson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0315","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"J R Stat Soc: Ser B (Stat Methodol)"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0320","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1098\/rstb.1999.0428","article-title":"Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys","volume":"354","author":"Ferguson","year":"1999","journal-title":"Philos Trans R Soc London, Ser B: Biol Sci"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0325","doi-asserted-by":"crossref","first-page":"e0003719","DOI":"10.1371\/journal.pntd.0003719","article-title":"Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries","volume":"9","author":"Imai","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0330","doi-asserted-by":"crossref","first-page":"e3306","DOI":"10.1371\/journal.pntd.0003306","article-title":"Approaches to refining estimates of global burden and economics of dengue","volume":"8","author":"Shepard","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0335","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/aje\/kwt256","article-title":"Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control","volume":"179","author":"Rodriguez-Barraquer","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0972-9062.141704","article-title":"On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling","volume":"51","author":"Mizumoto","year":"2014","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0345","doi-asserted-by":"crossref","first-page":"20130414","DOI":"10.1098\/rsif.2013.0414","article-title":"Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity","volume":"10","author":"Reich","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0355","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0360","doi-asserted-by":"crossref","first-page":"e1180","DOI":"10.1371\/journal.pntd.0001180","article-title":"Age-specificity of clinical dengue during primary and secondary infections","volume":"5","author":"Thai","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0365","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3201\/eid1306.070008","article-title":"Age and clinical dengue illness","volume":"13","author":"Egger","year":"2007","journal-title":"Emergy Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0370","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.vaccine.2013.11.020","article-title":"Potential opportunities and perils of imperfect dengue vaccines","volume":"32","author":"Rodriguez-Barraquer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0380","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2014.09.004","article-title":"Key challenges in infectious disease modelling using data from multiple sources","volume":"10","author":"De Angelis","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0390","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1467-9868.2009.00736.x","article-title":"Particle markov chain monte carlo methods","volume":"72","author":"Andrieu","year":"2010","journal-title":"J R Stat Soc: Ser B: Stat Methodol"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0395","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature13529","article-title":"A dynamic model of bovine tuberculosis spread and control in Great Britain","volume":"511","author":"Brooks-Pollock","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.11.023_bib0400","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15016655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15016655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:17:32Z","timestamp":1718194652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15016655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":40,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X15016655"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725969004.793512563","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}